Will Biomarkers Succeed as a Surrogate Endpoint in Heart Failure Trials?

被引：9
|
作者：
Januzzi, James L., Jr. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Cardiol Div, 32 Fruit St,Yawkey 5984, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA USA
来源：
JACC-HEART FAILURE | 2018年 / 6卷 / 07期
关键词：
biomarker; heart failure; outcomes;
D O I：
10.1016/j.jchf.2018.02.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：570 / 572
页数：3
相关论文
共 50 条
  • [1] Biomarkers as Surrogate End Points in Heart Failure Trials
    Felker, G. Michael
    HEART FAILURE CLINICS, 2011, 7 (04) : 501 - +
  • [2] Beyond dyspnoea as an endpoint in acute heart failure trials
    Gheorghiade, Mihai
    Ruschitzka, Frank
    EUROPEAN HEART JOURNAL, 2011, 32 (12) : 1442 - 1445
  • [3] Microalbuminuria as Surrogate Endpoint in Therapeutic Trials
    Redon, Josep
    Martinez, Fernando
    CURRENT HYPERTENSION REPORTS, 2012, 14 (04) : 345 - 349
  • [4] Imaging Surrogate End Points in Heart Failure Trials
    Bettari, Luca
    Borges-Neto, Salvador
    HEART FAILURE CLINICS, 2011, 7 (04) : 509 - +
  • [5] Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition
    Zannad, Faiez
    Stough, Wendy Gattis
    Pitt, Bertram
    Cleland, John G. F.
    Adams, Kirkwood F.
    Geller, Nancy L.
    Torp-Pedersen, Christian
    Kirwan, Bridget-Anne
    Follath, Ferenc
    EUROPEAN HEART JOURNAL, 2008, 29 (03) : 413 - 421
  • [6] Nuclear Cardiology Surrogate Biomarkers in Clinical Trials
    Miller, Robert J. H.
    Patel, Krishna K.
    Kwiecinski, Jacek
    Slipczuk, Leandro
    Dweck, Marc
    Newby, David E.
    Chareonthaitawee, Panithaya
    Slomka, Piotr
    JOURNAL OF NUCLEAR MEDICINE, 2025, 66 (01) : 4 - 11
  • [7] Redefining the role of biomarkers in heart failure trials: expert consensus document
    Kramer, Frank
    Sabbah, Hani N.
    Januzzi, James J.
    Zannad, Faiez
    van Tintelen, J. Peter
    Schelbert, Erik B.
    Kim, Raymond J.
    Milting, Hendrik
    Vonk, Richardus
    Neudeck, Brien
    Clark, Richard
    Witte, Klaus
    Dinh, Wilfried
    Pieske, Burkert
    Butler, Javed
    Gheorghiade, Mihai
    HEART FAILURE REVIEWS, 2017, 22 (03) : 263 - 277
  • [8] Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure
    Vaduganathan, Muthiah
    Claggett, Brian
    Packer, Milton
    McMurray, John J. V.
    Rouleau, Jean L.
    Zile, Michael R.
    Swedberg, Karl
    Solomon, Scott D.
    JACC-HEART FAILURE, 2018, 6 (07) : 564 - 569
  • [9] Redefining the role of biomarkers in heart failure trials: expert consensus document
    Frank Kramer
    Hani N. Sabbah
    James J. Januzzi
    Faiez Zannad
    J. Peter van Tintelen
    Erik B. Schelbert
    Raymond J. Kim
    Hendrik Milting
    Richardus Vonk
    Brien Neudeck
    Richard Clark
    Klaus Witte
    Wilfried Dinh
    Burkert Pieske
    Javed Butler
    Mihai Gheorghiade
    Heart Failure Reviews, 2017, 22 : 263 - 277
  • [10] Validation of Exercise Capacity as a Surrogate Endpoint in Exercise-Based Rehabilitation for Heart Failure A Meta-Analysis of Randomized Controlled Trials
    Ciani, Oriana
    Piepoli, Massimo
    Smart, Neil
    Uddin, Jamal
    Walker, Sarah
    Warren, Fiona C.
    Zwisler, Ann D.
    Davos, Constantinos H.
    Taylor, Rod S.
    JACC-HEART FAILURE, 2018, 6 (07) : 596 - 604
12345